ID Source | ID |
---|---|
PubMed CID | 128419 |
CHEBI ID | 18225 |
SCHEMBL ID | 9872231 |
SCHEMBL ID | 5003539 |
MeSH ID | M0147430 |
Synonym |
---|
myo-inositol 1,3-bis(dihydrogen phosphate) |
CHEBI:18225 |
phosphoric acid mono-(2,3,4,6-tetrahydroxy-5-phosphonooxy-cyclohexyl) ester |
C04062 |
d-myo-inositol 1,3-bisphosphate |
myo-inositol 1,3-bisphosphate |
103597-56-4 |
inositol 1,3-bisphosphate |
DB02942 |
1JOC , |
SCHEMBL9872231 |
[(1s,2r,4s,5r)-2,3,4,6-tetrahydroxy-5-phosphonooxycyclohexyl] dihydrogen phosphate |
inositol 1,3-diphosphate |
myo-inositol, 1,3-bis(dihydrogen phosphate) |
inositol(1,3)bisphosphate |
1,5,-ip2 |
[(1r,2s,4r,5s)-2,3,4,6-tetrahydroxy-5-phosphonooxycyclohexyl] dihydrogen phosphate |
gtpl5099 |
SCHEMBL5003539 |
d-myo-inositol-1,3-bis(dihydrogen phosphate) |
PUVHMWJJTITUGO-FICORBCRSA-N |
d-myo-inositol-1,3-diphosphate |
(1r,2s,3s,4r,5s,6s)-2,4,5,6-tetrahydroxycyclohexane-1,3-diyl bis[dihydrogen (phosphate)] |
Q27102919 |
Q27070780 |
[(1r,2s,4r,5s)-2,3,4,6-tetrahydroxy-5-phosphonooxy-cyclohexyl]oxyphosphonic acid |
DTXSID60869397 |
PD049692 |
Pathway | Proteins | Compounds |
---|---|---|
Metabolism | 1496 | 1108 |
Inositol phosphate metabolism | 32 | 35 |
Synthesis of IP2, IP, and Ins in the cytosol | 5 | 17 |
Protein | Taxonomy | Measurement | Average | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
---|---|---|---|---|---|---|---|
Chain A, Early Endosomal Autoantigen 1 | Homo sapiens (human) | Kd | 24.0000 | 24.0000 | 24.0000 | 24.0000 | AID977611 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID1811 | Experimentally measured binding affinity data derived from PDB | 2001 | Molecular cell, Nov, Volume: 8, Issue:5 | Multivalent endosome targeting by homodimeric EEA1. |
AID977611 | Experimentally measured binding affinity data (Kd) for protein-ligand complexes derived from PDB | 2001 | Molecular cell, Nov, Volume: 8, Issue:5 | Multivalent endosome targeting by homodimeric EEA1. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 2 (33.33) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 3 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.67) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 6 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |